Analysis of Outcomes and Prognostic Factors after Fertility-Sparing Surgery in Patients with Early Stage Juvenile Granulosa Cell Tumor of the Ovary: Experience from a Tertiary Center
- PMID: 34902562
- DOI: 10.1016/j.jpag.2021.12.005
Analysis of Outcomes and Prognostic Factors after Fertility-Sparing Surgery in Patients with Early Stage Juvenile Granulosa Cell Tumor of the Ovary: Experience from a Tertiary Center
Abstract
Study objective: The objective of the study was to analyze the oncological outcomes and prognostic factors in patients with early-stage juvenile granulosa cell tumor (JGCT) who underwent fertility-sparing surgery.
Design, setting, and participants: All patients with early-stage JGCT who underwent fertility-sparing surgery between January 1995 and December 2017 were reviewed retrospectively.
Interventions: None.
Main outcome measures: The risk factors for recurrence and death in patients with early-stage JGCT were identified.
Results: Thirty-five patients were eligible for the current study. The median age was 17 years (range: 4-30 years), and 10 patients were premenarchal. Nine patients were International Federation of Obstetrics and Gynecology stage IA, and 26 were stage IC. Eight subjects underwent complete staging, whereas 28 had no staging at their initial surgery. In those without initial staging, 3 patients who received initial unilateral salpingo-oophorectomy (USO) and 6 with initial cystectomy underwent secondary surgery for staging or USO with staging, respectively. At the time of the secondary staging operation, 1 of the subjects (treated with USO at initial surgery) was found to be stage III and was excluded from this study. Therefore, 8 patients underwent secondary staging surgery performed by laparoscopic surgery, and none of them suffered recurrence during follow-up. Fourteen of the 16 patients with complete staging surgery underwent lymphadenectomy, and none of them had lymph node metastasis. Thirty-one patients received adjuvant chemotherapy after surgery. Eight patients had disease recurrence after a median follow-up time of 51 months (range: 6-229 months), with a median time to recurrence of 4.5 months (range: 2-52 months). Six patients died of their disease. The 5-year disease-free and overall survival rates were 74.8% and 84.3%, respectively. Univariate analysis showed that incomplete staging surgery was associated with increased risk of recurrence (P = 0.029). Adjuvant chemotherapy was not associated with disease-free survival. Four patients had a total of 6 pregnancies, resulting in 6 live births.
Conclusion: Complete surgical staging is recommended for early-stage JGCT, but lymph node dissection can be omitted. Laparoscopic restaging surgery is feasible for patients with incomplete staging at initial surgery. However, the prognosis of patients with relapsed JGCT remains poor.
Keywords: Fertility-sparing surgery; Juvenile granulosa cell tumor; Ovary; Prognosis.
Copyright © 2021. Published by Elsevier Inc.
Similar articles
-
[Clinical characteristics and prognosis of ovarian juvenile granulosa cell tumors].Zhonghua Fu Chan Ke Za Zhi. 2025 Jan 25;60(1):34-45. doi: 10.3760/cma.j.cn112141-20240825-00256. Zhonghua Fu Chan Ke Za Zhi. 2025. PMID: 39863551 Chinese.
-
Retrospective analysis of clinicopathological characteristics of 19 ovarian juvenile granulosa cell tumor cases.J Obstet Gynaecol Res. 2021 Jul;47(7):2492-2499. doi: 10.1111/jog.14805. Epub 2021 Apr 27. J Obstet Gynaecol Res. 2021. PMID: 33904645
-
Juvenile Granulosa Cell Tumor of the Ovary: A Clinicopathologic Study.J Pediatr Adolesc Gynecol. 2017 Feb;30(1):138-143. doi: 10.1016/j.jpag.2016.09.008. Epub 2016 Oct 1. J Pediatr Adolesc Gynecol. 2017. PMID: 27702598
-
Fertility sparing surgery in early stage epithelial ovarian cancer.J Gynecol Oncol. 2014 Oct;25(4):320-7. doi: 10.3802/jgo.2014.25.4.320. Epub 2014 Jun 18. J Gynecol Oncol. 2014. PMID: 25142621 Free PMC article. Review.
-
Fertility sparing surgery for early-stage clear cell carcinoma of the ovary; A systematic review and analysis of obstetric outcomes.Eur J Surg Oncol. 2021 Jun;47(6):1286-1291. doi: 10.1016/j.ejso.2021.01.016. Epub 2021 Jan 22. Eur J Surg Oncol. 2021. PMID: 33509613
Cited by
-
Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries.Cancer. 2025 May 1;131(9):e35862. doi: 10.1002/cncr.35862. Cancer. 2025. PMID: 40267023
-
A rare case: Pure Sertoli cell tumor uncovered in atrophic ovary during postmenopausal vault prolapse evaluation.Oncoscience. 2025 May 22;12:52-57. doi: 10.18632/oncoscience.619. eCollection 2025. Oncoscience. 2025. PMID: 40406374 Free PMC article.
-
The Prognostic Significance of Adjuvant Chemotherapy in Adult Ovarian Granulosa Cell Tumors: A Systematic Review and Meta-analysis.Cancer Control. 2023 Jan-Dec;30:10732748231215165. doi: 10.1177/10732748231215165. Cancer Control. 2023. PMID: 37957122 Free PMC article.
-
Granulosa tumor: two spontaneous pregnancies after combined medico-surgical treatment: case report and review of the literature.J Med Case Rep. 2023 Mar 30;17(1):135. doi: 10.1186/s13256-023-03793-5. J Med Case Rep. 2023. PMID: 36998093 Free PMC article. Review.
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical